• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α-突触核蛋白通过与 SPTBN1 相互作用调节神经突生长。

α-Synuclein modulates neurite outgrowth by interacting with SPTBN1.

机构信息

Department of Molecular Biology, Sejong University, 98 Gunja-dong, Kwangjin-gu, Seoul 143-747, Republic of Korea.

出版信息

Biochem Biophys Res Commun. 2012 Aug 3;424(3):497-502. doi: 10.1016/j.bbrc.2012.06.143. Epub 2012 Jul 4.

DOI:10.1016/j.bbrc.2012.06.143
PMID:22771809
Abstract

α-Synuclein is the major component of Lewy bodies and Lewy neurites, the pathological hallmarks of surviving neuronal cells in Parkinson's disease patients. However, the physiological role played by α-synuclein remains unclear. In this study, spectrin beta non-erythrocyte 1 (SPTBN1) interacted with α-synuclein in phage display assays using a normalized human brain cDNA library. A direct interaction between α-synuclein and SPTBN1 was confirmed by GST pull-down and co-immunoprecipitation assays. SPTBN1 and α-synuclein proteins colocalized in N2a neuronal cells. Transfection of SPTBN1 caused human SH-SY5Y dopaminergic neuron cells to inappropriately induce neurites, which extended from cell bodies. Cotransfection with α-synuclein reversed SPTBN1-induced excessive neurite branching in SH-SY5Y cells, and only a single neurite extended from each neuron. These results suggest that α-synuclein modulates neurite outgrowth by interacting with cytoskeletal proteins such as SPTBN1.

摘要

α-突触核蛋白是路易体和路易神经突的主要成分,是帕金森病患者存活神经元细胞的病理标志。然而,α-突触核蛋白的生理作用尚不清楚。在这项研究中,使用标准化的人类大脑 cDNA 文库,在噬菌体展示实验中, spectrin beta non-erythrocyte 1(SPTBN1)与 α-突触核蛋白相互作用。通过 GST 下拉和共免疫沉淀实验证实了 α-突触核蛋白和 SPTBN1 之间的直接相互作用。SPTBN1 和 α-突触核蛋白蛋白在 N2a 神经元细胞中发生共定位。转染 SPTBN1 导致人 SH-SY5Y 多巴胺能神经元细胞不恰当地诱导神经突从细胞体延伸。与 α-突触核蛋白共转染可逆转 SH-SY5Y 细胞中 SPTBN1 诱导的过度神经突分支,并且每个神经元仅从单个神经元延伸。这些结果表明,α-突触核蛋白通过与细胞骨架蛋白如 SPTBN1 相互作用来调节神经突生长。

相似文献

1
α-Synuclein modulates neurite outgrowth by interacting with SPTBN1.α-突触核蛋白通过与 SPTBN1 相互作用调节神经突生长。
Biochem Biophys Res Commun. 2012 Aug 3;424(3):497-502. doi: 10.1016/j.bbrc.2012.06.143. Epub 2012 Jul 4.
2
Human α-synuclein modulates vesicle trafficking through its interaction with prenylated Rab acceptor protein 1.人源α-突触核蛋白通过与异戊烯化 Rab 受体蛋白 1 相互作用调节囊泡运输。
Biochem Biophys Res Commun. 2011 Sep 9;412(4):526-31. doi: 10.1016/j.bbrc.2011.07.028. Epub 2011 Jul 21.
3
Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.在帕金森病早期,α-突触核蛋白重新分布至黑质中的神经黑素脂质。
Brain. 2005 Nov;128(Pt 11):2654-64. doi: 10.1093/brain/awh584. Epub 2005 Jul 6.
4
Dopamine facilitates alpha-synuclein oligomerization in human neuroblastoma SH-SY5Y cells.多巴胺促进人神经母细胞瘤 SH-SY5Y 细胞中α-突触核蛋白寡聚化。
Biochem Biophys Res Commun. 2010 Jan 1;391(1):129-34. doi: 10.1016/j.bbrc.2009.11.015. Epub 2009 Nov 11.
5
Gene co-expression analysis of the human substantia nigra identifies BMP2 as a neurotrophic factor that can promote neurite growth in cells overexpressing wild-type or A53T α-synuclein.人类黑质的基因共表达分析鉴定出 BMP2 是一种神经营养因子,可促进过度表达野生型或 A53T α-突触核蛋白的细胞中的轴突生长。
Parkinsonism Relat Disord. 2019 Jul;64:194-201. doi: 10.1016/j.parkreldis.2019.04.008. Epub 2019 Apr 11.
6
Gelsolin co-occurs with Lewy bodies in vivo and accelerates α-synuclein aggregation in vitro.凝胶蛋白与路易体在体内共存,并在体外加速α-突触核蛋白聚集。
Biochem Biophys Res Commun. 2011 Aug 19;412(1):32-8. doi: 10.1016/j.bbrc.2011.07.027. Epub 2011 Jul 21.
7
alpha-Synucleinopathy in the human olfactory system in Parkinson's disease: involvement of calcium-binding protein- and substance P-positive cells.帕金森病患者嗅觉系统中的α-突触核蛋白病:钙结合蛋白和 P 物质阳性细胞的参与。
Acta Neuropathol. 2010 Jun;119(6):723-35. doi: 10.1007/s00401-010-0687-9. Epub 2010 Apr 11.
8
Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.脑内 α-突触核蛋白在多系统萎缩、帕金森病和进行性核上性麻痹中的蓄积:一项比较性研究。
Brain. 2010 Jan;133(Pt 1):172-88. doi: 10.1093/brain/awp282. Epub 2009 Nov 10.
9
G protein-coupled receptor kinase 5, overexpressed in the alpha-synuclein up-regulation model of Parkinson's disease, regulates bcl-2 expression.G 蛋白偶联受体激酶 5 在帕金森病的 α-突触核蛋白上调模型中过表达,调节 bcl-2 的表达。
Brain Res. 2010 Jan 11;1307:134-41. doi: 10.1016/j.brainres.2009.10.036. Epub 2009 Oct 21.
10
alpha-Synuclein is colocalized with 14-3-3 and synphilin-1 in A53T transgenic mice.在A53T转基因小鼠中,α-突触核蛋白与14-3-3和突触结合蛋白-1共定位。
Acta Neuropathol. 2006 Dec;112(6):681-9. doi: 10.1007/s00401-006-0132-2. Epub 2006 Sep 7.

引用本文的文献

1
Simultaneous RNA Sequencing and DNA Methylation Profiling Reveals Neural Mechanisms That Regulate Sensitive Period Behavioral Learning.同步RNA测序与DNA甲基化分析揭示调控敏感期行为学习的神经机制
Genes Brain Behav. 2025 Aug;24(4):e70031. doi: 10.1111/gbb.70031.
2
E46K α-Synuclein Mutation Fails to Promote Neurite Outgrowth by Not Inducing Cdc42EP2 Expression, Unlike Wild-Type or A53T α-Synuclein in SK-N-SH Cells.与野生型或A53T α-突触核蛋白不同,E46K α-突触核蛋白突变体在SK-N-SH细胞中不能诱导Cdc42EP2表达,因而无法促进神经突生长。
Brain Sci. 2024 Dec 25;15(1):9. doi: 10.3390/brainsci15010009.
3
Exploring α-synuclein Interaction Partners and their Potential Clinical Implications for Parkinson's Disease.
探索α-突触核蛋白的相互作用伙伴及其对帕金森病的潜在临床意义。
Neurochem Res. 2024 Nov 19;50(1):23. doi: 10.1007/s11064-024-04250-5.
4
Recent advances in novel mutation genes of Parkinson's disease.帕金森病新型突变基因的研究进展。
J Neurol. 2023 Aug;270(8):3723-3732. doi: 10.1007/s00415-023-11781-4. Epub 2023 May 24.
5
α-Synuclein Promotes Neuronal Dysfunction and Death by Disrupting the Binding of Ankyrin to β-Spectrin.α-突触核蛋白通过破坏锚蛋白与β- spectrin 的结合促进神经元功能障碍和死亡。
J Neurosci. 2023 Mar 1;43(9):1614-1626. doi: 10.1523/JNEUROSCI.1922-22.2022. Epub 2023 Jan 18.
6
Alpha and Beta Synucleins: From Pathophysiology to Clinical Application as Biomarkers.α-突触核蛋白和β-突触核蛋白:从病理生理学到作为生物标志物的临床应用
Mov Disord. 2022 Apr;37(4):669-683. doi: 10.1002/mds.28941. Epub 2022 Feb 5.
7
Identification of sixteen novel candidate genes for late onset Parkinson's disease.鉴定十六个新的晚发性帕金森病候选基因。
Mol Neurodegener. 2021 Jun 21;16(1):35. doi: 10.1186/s13024-021-00455-2.
8
Heterozygous variants in SPTBN1 cause intellectual disability and autism.SPTBN1 杂合变异导致智力残疾和自闭症。
Am J Med Genet A. 2021 Jul;185(7):2037-2045. doi: 10.1002/ajmg.a.62201. Epub 2021 Apr 13.
9
Pathomechanism Characterization and Potential Therapeutics Identification for Parkinson's Disease Targeting Neuroinflammation.针对神经炎症的帕金森病的病理机制特征分析及潜在治疗药物的鉴定。
Int J Mol Sci. 2021 Jan 21;22(3):1062. doi: 10.3390/ijms22031062.
10
βII spectrin (SPTBN1): biological function and clinical potential in cancer and other diseases.βII spectrin(SPTBN1):在癌症和其他疾病中的生物学功能和临床潜力。
Int J Biol Sci. 2021 Jan 1;17(1):32-49. doi: 10.7150/ijbs.52375. eCollection 2021.